The Fastest Path to Commercial Insights
We help life sciences teams get smart – fast – on any disease market and answer critical commercial questions with fresh KOL-driven insights delivered in as little as four weeks.
Meet with our team to chat about our new Special Topics reports, and how to add in complimentary proprietary questions.
Brain-Shuttle Technology: Expert Insights
Publishing October 2026
Meet tight deadlines without
sacrificing rigor
Pipeline planning doesn't pause for lengthy research timelines.
REACH helps pharmaceutical and biotech teams:
- Build foundational market understanding
- Define and refine target product profiles
- Prioritize indications
- Develop a business case for an asset
- Triangulate key data and pressure-test internal assumptions
On-demand commercial assessments
delivered in 4 weeks
Rare disease is our core strength –
and where we go deepest.
We built our expertise by answering commercial questions in rare disease markets where the standard of care is shifting, evidence is fragmented or absent, and secondary research alone falls short. We bring that same primary-research rigor and thoughtful interpretation to oncology, niche subpopulations of prevalent diseases, and other complex markets.
See Our Disease Coverage →Our Capabilities
Tailored, on-demand reports built from fresh KOL input to answer your toughest questions.
Disease Commercial Assessment
Understand the market today, how it is likely to evolve, and where the opportunities lie
Learn More ›Quantitative and qualitative research, recruited and moderated entirely by our team. Physicians are hand-picked from our own panel — ideal for dynamic, fast-moving markets.
Team members with 10+ years of experience in pharma market research don't just oversee the work. They do the work.
Choose the research approach that fits your needs
Whether you need a comprehensive commercial assessment or focused answers to specific questions, REACH can tailor the scope and timeline.
Need to get smart on a market?
Get a cost-effective, forward-looking view of an unfamiliar market. Choose the depth you need – from a concise market primer to a comprehensive commercial assessment with fresh physician insights and optional TPP testing and payer research. Access existing intelligence immediately or commission a new or refreshed assessment in as little as four weeks.
Explore MarketVue® →Already know your market?
Skip foundational landscape research and go straight to focused primary research addressing your proprietary business questions – delivered in as little as 3 weeks.
Explore Rapid Insights →From order to insights
Request
Tell us the disease or business question you're facing
Questions
We scope the study and finalize your priority questions
Research
Fresh KOL interviews and/or surveys, conducted by our senior team
Deliver
A clear, presentation-ready report — insights you can act on
"I need something beyond what I can do for myself with Google and without paying an extraordinary amount of money… REACH operates with the best aspects of primary research but then benefits like speed of syndicated reports."
"MarketVue® is very valuable to get fast reports and at the right level of detail. We were originally supposed to develop disease strategies but then we had a reorganization and resources were constrained. REACH is a great help to us."
"With MarketVue® reports, you can get 80–90% of output for 10% of the cost of custom consulting — this is great, especially for small clients like us whose budgets are tight, and we don't have a ton of FTEs."
"MarketVue® is really high quality in general and comparable to much more expensive reports where you get a 100-page report — in terms of value for the amount we use it, it is comparable to much, much more expensive research."
"REACH reports give you the ability to tailor the research a little bit more. I work in rare disease where syndicated reports just don't exist and if they do, they're not built out. I value the REACH team's ability and willingness to answer follow up questions, dive in around specific topics, and think critically with us around the implications of the findings."
"What pushed me over the edge was that they have a nice way of presenting the findings in the end. Their output was very clean and useful for putting into our slides. REACH can be a thought partner — they take what we're saying and riff off of us, then come up with additional ideas."
Get the insights you need to move forward
Reach out to our experts to see how we can help.